2024年布基纳法索风湿性关节炎的全科医生和非风湿学家的知识,态度和实践:2024年布基纳法索风湿性关节炎的跨部门研究:一项跨部门研究
Ismael Ayouba Tinni1, Wendyam Nadège Yameogo1, Yannick Laurent Tchenadoyo Bayala1
1Rheumatology Department Bogodogo University Hospital Ouagadougou Burkina Faso.
Health science reports
|July 21, 2025
概括
这项研究评估了卫生保健提供者在撒哈拉以南非洲对类风湿关节炎的知识,态度和做法. 大多数医生表现出可以接受的知识,态度和做法,尽管诊断挑战.
科学领域:
- 类风湿病学 类风湿病学
- 公共卫生 公共卫生
- 医学教育 医学教育
背景情况:
- 风湿性关节炎 (RA) 诊断在撒哈拉以南非洲经常被推迟,原因是医务人员对疾病的理解不足.
- 这种知识差距会影响患者的治疗结果和疾病管理.
研究的目的:
- 评估全科医生和非风湿病专家关于布基纳法索风湿性关节炎的知识,态度和做法.
- 识别 RA 及时和准确的诊断和管理的潜在障碍.
主要方法:
- 从2024年1月22日至2月22日进行了一项描述性和分析性横截面研究.
- 数据是通过在线自行管理问卷从布基纳法索的145名医生收集的.
- 统计分析包括二次测试,以评估变量之间的关联.
主要成果:
- 平均知识分数为12.51/20,态度分数为9.64/20,实践分数为14.76/20.
- 平均/良好知识的医生在了解生物疗法方面表现出显著的差距 (72.90%) 和不利的态度 (58.30%).
- 在平均/良好的知识和不充分的实践之间发现了显著的关联 (p=0.019).
结论:
- 该研究中的大多数医生表现出了有关类风湿性关节炎的可接受水平的知识,态度和实践.
- 尽管总体可接受的分数,但特定领域,如生物疗法理解需要进一步关注,以改善RA护理.
相关概念视频
Genome-wide Association Studies-GWAS
14.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.3K
Rheumatic Heart Disease III: Medical Management
33
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
33
Rheumatic Heart Disease I: Introduction
46
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
46
Rheumatic Heart Disease IV: Nursing Management
38
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
38
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
65
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
65
Primary Healthcare Services
1.5K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
1.5K


